Toxoplasmosis encephalitis following severe graft-vs.-host disease after allogeneic hematopoietic stem cell transplantation: 17 Yr experience in Fukuoka BMT group

European Journal of Haematology

Volumn 79, Issue 4, 2007, Pages 317-321

  Matsuo, Yayoi ^a   Takeishi, Shoichiro ^a   Miyamoto, Toshihiro ^a,e   Nonami, Atsushi ^a   Kikushige, Yoshikane ^a   Kunisaki, Yuya ^a   Kamezaki, Kenjiro ^a   Tu, Liping ^a   Hisaeda, Hajime ^a   Takenaka, Katsuto ^a   Harada, Naoki ^a   Kamimura, Tomohiko ^b   Ohno, Yuju ^c   Eto, Tetsuya ^d   Teshima, Takanori ^a   Gondo, Hisashi ^a   Harada, Mine ^a   Nagafuji, Koji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HARASANSHIN HOSPITAL   (Japan)

^c KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^d HAMANOMACHI HOSPITAL   (Japan)

^e KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Encephalitis; Graft vs. host disease; Hematopoietic stem cell transplantation; Polymerase chain reaction; Toxoplasmosis

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRIMETHAMINE SULFADIAZINE;

ADULT; ANAMNESIS; ARTICLE; BACTERIAL INFECTION; BRAIN EDEMA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIAGNOSTIC PROCEDURE; ENCEPHALITIS; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIMALARIALS; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL INFECTIONS; CD4 LYMPHOCYTE COUNT; DNA, PROTOZOAN; ENCEPHALITIS; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; JAPAN; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548586992     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00919.x     Document Type: Article

References (23)

1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004 363: 1965 76.
2. Kasper LH, Buzoni-Gatel D. Some opportunistic parasitic infections in AIDS: candidiasis, pneumocystosis, cryptosporidiosis, toxoplasmosis. Parasitol Today 1998 14: 150 6.
3. Martino R, Bretagne S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000 25: 1111 4.
4. Mueller-Mang C, Mang TG, Kalhs P, Thurnher MM. Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology 2006 48: 84 9.
5. Derouin F, Gluckman E, Beauvais B, et al. Toxoplasma infection after human allogeneic bone marrow transplantation: clinical and serological study of 80 patients. Bone Marrow Transplant 1986 1: 67 73.
6. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994 13: 549 57.
7. Small TN, Leung L, Stiles J, et al. Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone Marrow Transplant 2000 25: 969 73.
8. Yamaoka M, Konishi E. Prevalence of antibody to Toxoplasma gondii among inhabitants under different geographical and climatic conditions in Hyogo Prefecture, Japan. Jpn J Med Sci Biol 1993 46: 121 9.
9. Khin Sane W, Matsumura T, Kumagai S, Uga S, Konishi E. Prevalence of antibody to Toxoplasma gondii in Hyogo Prefecture, Japan: comparison at a 10-year interval. Kobe J Med Sci 1997 43: 159 68.
10. +-selected autologous peripheral blood stem cell transplantation. Haematologica 2000 85: 334 5.
11. Ellis JT. Polymerase chain reaction approaches for the detection of Neospora caninum and Toxoplasma gondii. Int J Parasitol 1998 28: 1053 60.
12. Martino R, Maertens J, Bretagne S, et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000 31: 1188 95.
13. Held TK, Kruger D, Switala AR, et al. Diagnosis of toxoplasmosis in bone marrow transplant recipients: comparison of PCR-based results and immunohistochemistry. Bone Marrow Transplant 2000 25: 1257 62.
14. Bretagne S, Costa JM, Foulet F, Jabot-Lestang L, Baud-Camus F, Cordonnier C. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl Infect Dis 2000 2: 127 32.
15. Costa JM, Pautas C, Ernault P, Foulet F, Cordonnier C, Bretagne S. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000 38: 2929 32.
16. Martino R, Bretagne S, Einsele H, et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005 40: 67 78.
17. Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989 27: 1787 92.
18. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant 1997 19: 685 9.
19. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med 1993 329: 995 1000.
20. Ionita C, Wasay M, Balos L, Bakshi R. MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. Am J Neuroradiol 2004 25: 270 3.
21. Saiz A, Graus F. Neurological complications of hematopoietic cell transplantation. Semin Neurol 2004 24: 427 34.
22. Maury S, Mary JY, Rabian C, et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001 115: 630 41.
23. Reusser P, Einsele H, Lee J, et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002 99: 1159 64.